{
    "timestamp": "Aug 12, 2025 10:18 AM EST",
    "stats": {
        "input_words": 1337820,
        "output_words": 506,
        "filings_processed": 8
    },
    "filings": [
        {
            "company_name": "Cardinal Health",
            "stock": "CAH",
            "wiki_url": "https://en.wikipedia.org/wiki/Cardinal_Health",
            "change_percent": 0.31,
            "price": 157.88,
            "filing_type": "10-K",
            "filing_time": "2025-08-12T08:58:00-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/721371/000072137125000079/0000721371-25-000079-index.htm",
            "accession_number": "0000721371-25-000079",
            "summary_points": [
                "1.  On August 12, 2025, the company announced an agreement to acquire Solaris Health for approximately $1.9 billion in cash, with an estimated $500 million in grant date fair value of common units issued to certain physicians and management.",
                "2.  Following the acquisition of Solaris Health, the company will own approximately 75% of The Specialty Alliance, its multi-specialty MSO platform.",
                "3. The total expense for employee retirement savings plans was $89 million in fiscal year 2025, compared to $65 million in 2024 and $66 million in 2023."
            ]
        },
        {
            "company_name": "Sherwin-Williams",
            "stock": "SHW",
            "wiki_url": "https://en.wikipedia.org/wiki/Sherwin-Williams",
            "change_percent": 0,
            "price": 354.7,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T07:30:22-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/89800/000119312525178475/0001193125-25-178475-index.htm",
            "accession_number": "0001193125-25-178475",
            "summary_points": [
                "Failed to analyze filing"
            ]
        },
        {
            "company_name": "Cardinal Health",
            "stock": "CAH",
            "wiki_url": "https://en.wikipedia.org/wiki/Cardinal_Health",
            "change_percent": 0,
            "price": 157.88,
            "filing_type": "8-K",
            "filing_time": "2025-08-12T06:59:12-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/721371/000072137125000075/0000721371-25-000075-index.htm",
            "accession_number": "0000721371-25-000075",
            "summary_points": [
                "1. Cardinal Health's Q4 2025 revenue was $60.2 billion, relatively flat year-over-year but up 21% excluding a previously announced contract expiration.",
                "2. Fiscal year 2026 non-GAAP diluted EPS guidance was raised to $9.30-$9.50, a $0.20 increase from the previous outlook.",
                "3. Cardinal Health announced a definitive agreement to acquire Solaris Health for approximately $1.9 billion in cash,  expected to close by the end of calendar year 2025 and be slightly accretive to non-GAAP EPS in the first 12 months following the close."
            ]
        },
        {
            "company_name": "Celanese",
            "stock": "CE",
            "wiki_url": "https://en.wikipedia.org/wiki/Celanese",
            "change_percent": 0,
            "price": 47.29,
            "filing_type": "8-K",
            "filing_time": "2025-08-11T17:30:39-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1306830/000110465925076253/0001104659-25-076253-index.htm",
            "accession_number": "0001104659-25-076253",
            "summary_points": [
                "Failed to analyze filing"
            ]
        },
        {
            "company_name": "Jack Henry & Associates",
            "stock": "JKHY",
            "wiki_url": "https://en.wikipedia.org/wiki/Jack_Henry_%26_Associates",
            "change_percent": 0,
            "price": 158.59,
            "filing_type": "8-K",
            "filing_time": "2025-08-11T16:53:33-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/779152/000077915225000049/0000779152-25-000049-index.htm",
            "accession_number": "0000779152-25-000049",
            "summary_points": [
                "1. Jack Henry & Associates, Inc. reported $20.5 million in deconversion revenue for the fiscal fourth quarter ended June 30, 2025, bringing the full fiscal year total to $33.9 million.",
                "2.  Deconversion revenue, excluded from non-GAAP revenue reporting, is driven by factors outside of Jack Henry's control and does not represent the company's ongoing business operations.",
                "3. The company issued a press release on August 11, 2025, announcing its deconversion revenue for the fiscal fourth quarter and full fiscal year ended June 30, 2025."
            ]
        },
        {
            "company_name": "Celanese",
            "stock": "CE",
            "wiki_url": "https://en.wikipedia.org/wiki/Celanese",
            "change_percent": 0,
            "price": 47.29,
            "filing_type": "10-Q",
            "filing_time": "2025-08-11T16:36:44-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1306830/000130683025000174/0001306830-25-000174-index.htm",
            "accession_number": "0001306830-25-000174",
            "summary_points": [
                "1. As of June 30, 2025, Celanese had $725 million of remaining performance obligations related to take-or-pay contracts, with $269 million expected to be recognized as net sales in 2025, $238 million in 2026, and $114 million in 2027.",
                "2.  Celanese incurred $40 million in restructuring charges during the first six months of 2025, compared to $48 million during the same period in 2024.",
                "3. On August 11, 2025, Celanese replaced its U.S. Revolving Credit Facility with a new $1.75 billion senior unsecured revolving credit facility maturing in 2030, with a margin of 1.00% to 2.00% above certain interbank rates (or 0.00% to 1.00% for U.S. dollar base rate borrowings)."
            ]
        },
        {
            "company_name": "Lam Research",
            "stock": "LRCX",
            "wiki_url": "https://en.wikipedia.org/wiki/Lam_Research",
            "change_percent": 0,
            "price": 101.99,
            "filing_type": "10-K",
            "filing_time": "2025-08-11T16:35:11-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/707549/000070754925000075/0000707549-25-000075-index.htm",
            "accession_number": "0000707549-25-000075",
            "summary_points": [
                "1.  A 15-year tax incentive ruling in Malaysia, effective from fiscal year 2022, decreased worldwide taxes by approximately $584.8 million in fiscal year 2025.",
                "2.  Approximately $1.3 billion in earnings from foreign subsidiaries are indefinitely reinvested as of June 29, 2025; remitting these earnings to the US would incur approximately $152.1 million in foreign withholding taxes, offset by $121.7 million in foreign tax credits.",
                "3. The Omnibus Budget and Budget Reconciliation Act (OBBBA), signed into law on July 4, 2025, will impact income taxes in fiscal year 2026, and the company is assessing its potential implications."
            ]
        },
        {
            "company_name": "Celanese",
            "stock": "CE",
            "wiki_url": "https://en.wikipedia.org/wiki/Celanese",
            "change_percent": 0,
            "price": 47.29,
            "filing_type": "8-K",
            "filing_time": "2025-08-11T16:27:19-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1306830/000130683025000173/0001306830-25-000173-index.htm",
            "accession_number": "0001306830-25-000173",
            "summary_points": [
                "1. Celanese Corporation's Q2 2025 adjusted EPS was $1.44, including $0.38 from transaction amortization.",
                "2. First-half 2025 free cash flow increased by approximately 80% year-over-year.",
                "3. Celanese projects a $35 million headwind to Q3 2025 EM adjusted EBIT due to weaker demand and inventory reductions."
            ]
        }
    ]
}